D-Serine>98.5%(T)5g

(4aS,7R,8aS)-9,9-Dimethyltetrahydro-4H-4a,7-methanobenzo[c][1,2]oxazireno[2,3-b]isothiazole 3,3-dioxide, 95.0%, 1g

4-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)picolinonitrile, 98.0%, 250mg

ETHYL 2-CHLORO-6H-THIENO[2,3-B]PYRROLE-5-CARBOXYLATE, 95.0%, 250mg

Oxion Inverso OX.2053-PLPH-ICSI avec objectifs LWD Plan phase 10x/20x/40x, équipement ICSI et table croisée XY

2-(2-(2-METHOXYETHOXY)ETHOXY)ETHYL 4-METHYLBENZENESULFONATE, 95.0%, 250mg

Fmoc-Arg-OH, 95%, 25g

2,2,3-trimethylpyrrolidine, 95.0%, 5g

4-chloro-5,6-dimethyl-2-pyrrolidin-1-ylpyrimidine, 95.0%, 5g

3-hydrazino-1-propanol dihydrochloride, 95.0%, 100mg

7-AMINO-4,5-DIHYDRO-1H-BENZO[B]AZEPIN-2(3H)-ONE, 95.0%, 250mg

3-Fluorophenylamine hydrochloride, 95.0%, 10g

3-Chloro-2-(trifluoromethyl)isonicotinic acid, 95.0%, 250mg